PF_06835919



NAME OF DRUG : PF_06835919

ALSO KNOWN AS : PF_06835919

LABORATORY : PFIZER

STATUS AND ADVANCEMENT

Type of drug : Ketohexokinase (KHK) Inhibitor

Clinical trials advancement : Initiating Phase 2b

Estimated time to market : 112 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON PF_06835919

SOME PUBLICATIONS RELATED WITH PF_06835919

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH PF_06835919


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE